Intersect ENT (XENT) PT Raised to $41 at Guggenheim, 'Sinuva Deep Dive Suggests Significant Upside Potential'
Guggenheim raised its price ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)